| Catalog# | Promotion  |
Size | Price | Availability |
| Form | Liquid |
| Description | Human anti-SARS-CoV-2 Spike Antibody [CR3022] recognizes human SARS-CoV and CoV-2 spike protein with high affinity. The binding site is amino acids 318-510 (RBD, Receptor Binding Domain) in the S1 subunit of the spike protein. Coronavirus spike protein conducts the process that interacts with cellular receptor and membrane fusion to allow virus entering into target cells. Spike protein also can be used to define the specificity of the virus and be used as a critical target for vaccine design. The glycosylated spike protein can be detected in the virus-infected cell and cell culture medium. The RBD is responsible for recognizing the cell surface receptor. |
| Reactivity | SARS-CoV & CoV-2 Spike protein |
| Clonality | Monoclonal, clone CR3022 |
| Concentration | 0.5 mg/mL |
| Conjugation | Unconjugated |
| Storage Buffer | Phosphate Buffered Saline, pH 7.4. |
| Isotype | IgM |
| Stability & Storage | The product is shipped with polar packs. Upon receipt, store it immediately at 2-8°C for long term storage. |
| Shipping | This product is stable after storage at: 2-8°C for 6 months under sterile conditions from date of receipt. Briefly centrifuge vials before opening. |
Recommended dilution factor:
ELISA: 1:5000-20000
NTRL: Assay dependent
SPR: Assay dependent
Crystallography: Assay dependent
Note: Working dilution for specific application should be determined by the investigator to obtain the best conditions.
No experimental data is available
No references are available
Follow Us
